Real-world experience tells another
Lets take a look at how these two medications work, their weight-loss potential, their similarities and differences, and whats still being studiedincluding when retatrutide might be approved
Biological actions of GLP-1, source: reference [1] Evolution of GLP1 GLP-1RAs Currently, there are nine GLP-1RAs approved for marketing worldwide (Table 1), mainly for the treatment of diabetes and obesity, of which tirzepatide is a novel dual GLP-1RA/GIPR agonist
The safest approach is to implement the foundational protocols, including protein, resistance training, hydration, and sleep optimization, regardless of whether you believe the stall will resolve on its own
Unfortunately, inadequate protein intake increases the risk of muscle loss, weakness, fatigue, and metabolic slowdown